glp-1 and ibd for Crohn's Disease: Current Evidence Treatment Options GLPs as novel therapeutic options

If your genes predispose you to aggressive weight regain, stopping medication is often counterproductivelike turning off insulin in a diabetic and expecting stable blood sugar

For example, GLP-1RAs were proven in the clinic to slow the disease progression of Alzheimers disease and Parkinsons disease, attributed in part to their anti-inflammatory and neuroprotective properties [16, 1822]

Thats because GLP-1s are designed to slow gastric emptying, the process of the stomachs contents being released into the small intestine to aid digestion

[19] [20] The risk of hypoglycemia increases when these medications are combined with insulin or sulfonylureas, often requiring dose adjustments of these agents

More research is needed to know for sure